Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile5 entries
2024
Hernia-mesh litigation settlement
BD agreed to settle approximately 38,000 United States lawsuits in which plaintiffs alleged injuries associated with BD hernia-mesh products.
2020
Transvaginal-mesh risk-disclosure penalties
C. R. Bard and BD were fined $60 million in connection with allegations that patients were not adequately informed about health risks related to transvaginal mesh devices.
2020
BD recalls sterile disposable injection needles in South Korea
Recall announced
Becton Dickinson Medical (S) Pte. Ltd. voluntarily recalled specified batches of sterile disposable injection needles following a customer complaint from South Korea. According to the complaint, some packaging may have been opened and incorrectly cut. The article states that the affected batch was not imported into China and that the recall did not affect the Chinese market.
Company response
Recall — Becton Dickinson Medical(S)Pte.Ltd.
生产商Becton Dickinson Medical(S)Pte.Ltd.对一次性使用无菌注射针（注册证号：国械注进20193141616）主动召回。
Source excerpt
生产商Becton Dickinson Medical(S)Pte.Ltd.对一次性使用无菌注射针（注册证号：国械注进20193141616）主动召回。
日前，碧迪医疗器械（上海）有限公司报告，由于涉及特定型号、特定批次产品可能存在包装开封并且包装被错误切割的问题。
该批号产品并未进口至我国，该召回事件不影响我国市场，故在我国不需采取任何行动和处理措施。本次召回涉及地区或国家为韩国。
2016
Occupational-safety violations
OSHA imposed a $112,700 penalty after finding repeat and serious workplace-safety violations associated with partial finger amputations suffered by two employees.
2004
Retractable Technologies antitrust dispute
BD agreed to pay approximately $100 million to settle allegations that it had used anticompetitive conduct to limit distribution of a competitor's safety syringes. The dispute continued through later patent and advertising-related conflicts.